Delivering health.

At Hepacura we are building the first specific health platform targeting chronic liver disease. In the U.S., fatty liver disease alone affects 65 million patients at an annual cost of $100 billion. Our platform leverages diagnostic AI, digital therapeutics and telehealth to support the patients holistically.



Philipp, CEO

Niklas, CPO

Martin, CTO

Daniel, COO


We’d love to hear from you! Click the button below to get in touch.